Eurofins buys U.S. Dx firm; BioClinica hires a new CFO;

> Testing outfit Eurofins Scientific traded $50 million for U.S. diagnostics firm Diatherix Laboratories. More

> BioClinica named former WCCT Global exec David Peters to be its next chief financial officer, replacing the retiring Ted Kaminer. News

> InVentiv Health appointed Michael McKelvey to the role of executive vice president and president of its clinical division, hiring a veteran of Aptiv, Parexel ($PRXL) and eResearchTechnology. Release

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.